IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MANCINI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.785
NA - Nord America 2.585
AS - Asia 2.422
Continente sconosciuto - Info sul continente non disponibili 308
SA - Sud America 209
AF - Africa 80
OC - Oceania 9
Totale 8.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.425
DE - Germania 747
CN - Cina 644
SG - Singapore 640
GB - Regno Unito 635
IT - Italia 438
VN - Vietnam 331
SE - Svezia 268
BD - Bangladesh 242
HK - Hong Kong 204
BR - Brasile 163
RU - Federazione Russa 154
CA - Canada 126
FR - Francia 116
IN - India 94
TR - Turchia 79
NL - Olanda 70
IE - Irlanda 62
FI - Finlandia 60
DK - Danimarca 44
CI - Costa d'Avorio 39
KR - Corea 37
UA - Ucraina 37
JP - Giappone 36
ID - Indonesia 26
BE - Belgio 21
PL - Polonia 19
AR - Argentina 17
AT - Austria 16
PH - Filippine 15
CH - Svizzera 14
ES - Italia 14
GR - Grecia 14
CZ - Repubblica Ceca 13
MX - Messico 11
IQ - Iraq 10
ZA - Sudafrica 10
IR - Iran 9
AU - Australia 8
EU - Europa 8
PT - Portogallo 8
CL - Cile 7
HU - Ungheria 7
PK - Pakistan 7
RO - Romania 7
CO - Colombia 6
CR - Costa Rica 6
KE - Kenya 6
MY - Malesia 6
EC - Ecuador 5
NO - Norvegia 5
NP - Nepal 5
SC - Seychelles 5
UZ - Uzbekistan 5
MA - Marocco 4
PE - Perù 4
SA - Arabia Saudita 4
SV - El Salvador 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
BY - Bielorussia 3
KZ - Kazakistan 3
LT - Lituania 3
MU - Mauritius 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
OM - Oman 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
Totale 8.093
Salva come PNG Salva come JPEG
Città #
Southend 562
Hanover 535
Singapore 357
Ashburn 339
Chandler 208
Hong Kong 174
San Jose 159
Milan 157
Beijing 121
Council Bluffs 111
Dallas 100
Los Angeles 95
Ho Chi Minh City 93
New York 86
Wilmington 85
Santa Clara 70
Hanoi 69
Princeton 67
Ann Arbor 61
Dublin 60
Seattle 55
Istanbul 51
Buffalo 49
Fairfield 49
Lauterbourg 46
Toronto 45
Abidjan 39
Frankfurt am Main 35
Ottawa 35
Helsinki 34
Rome 33
Houston 31
Bengaluru 30
Des Moines 28
Hangzhou 28
Moscow 27
Boardman 26
Guangzhou 26
Da Nang 25
Dearborn 24
Columbus 23
Phoenix 23
Woodbridge 23
Nanjing 22
Seoul 22
Shanghai 22
Hefei 21
Redwood City 21
Tokyo 20
Cambridge 18
Munich 18
Brussels 17
Jakarta 16
São Paulo 16
The Dalles 15
Boston 14
Falls Church 14
Berlin 12
Grafing 12
Haiphong 12
Jinan 12
Fremont 11
Mountain View 11
Naples 11
Zhengzhou 11
Cangzhou 10
Dong Ket 10
Fuzhou 10
Redmond 10
Shenyang 10
Warsaw 10
Denver 9
Tianjin 9
Turku 9
Amsterdam 8
Bến Tre 8
Chennai 8
Clark 8
Montreal 8
North Bergen 8
Prague 8
Wuhan 8
Athens 7
Brooklyn 7
Cagliari 7
Can Tho 7
Hebei 7
Johannesburg 7
London 7
Mumbai 7
New Delhi 7
Orem 7
Sakarya 7
San Francisco 7
Turin 7
Ankara 6
Atlanta 6
Central District 6
Jacksonville 6
Manchester 6
Totale 4.914
Salva come PNG Salva come JPEG
Nome #
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 508
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients 424
ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA 343
Thrombotic Thrombocytopenic Purpura (TTP) Database 329
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge 270
ADAMTS13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura 269
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians 263
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis 247
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity 241
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura 237
The ISTH Bleeding Assessment Tool and the risk of future bleeding 227
Different clinical severity of first episodes and recurrence of thrombotic thrombocytopenic purpura 225
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis 225
The ADAMTS13-von Willebrand factor axis in COVID-19 patients 221
Prevention of relapse in patients with acquired thrombotic thrombocytopenic purpura undergoing elective surgery: a case series 217
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients 216
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura 213
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura 212
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura 208
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis 194
Congenital and acquired ADAMTS13 deficiency: two mechanisms, one patient 192
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura 186
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study 182
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpura 180
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19 169
Measurement of anti-ADAMTS13 neutralising autoantibodies: a comparison between CBA and FRET assays 168
Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura 168
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project) 162
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy 161
Case report : use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura 158
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age 143
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease 133
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction 129
Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: The role of mycophenolate mofetil 126
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis 126
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura 115
Lombardy network for the study and treatment of patients undergoing apheresis 103
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura 91
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange 89
Acquired Thrombotic Thrombocytopenic Purpura Occurring in Advanced Age : Impact of a Delayed Onset on Disease Expression 89
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura 79
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease 79
Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura 77
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age 4
Totale 8.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.110 0 39 51 100 106 93 107 86 144 141 105 138
2022/2023712 102 115 70 69 76 119 7 54 61 2 24 13
2023/2024370 17 34 41 21 68 31 20 16 14 23 40 45
2024/20251.093 37 63 12 106 85 46 42 118 75 127 114 268
2025/20262.992 273 156 225 301 232 187 531 98 236 172 277 304
2026/2027309 147 162 0 0 0 0 0 0 0 0 0 0
Totale 8.398